MFDS
- Status: likely_approved
🇰🇷 Inspra in South Korea
Inspra (EPLERENONE) regulatory status in South Korea.
Marketing authorisations
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
MFDS
- Status: likely_approved
Inspra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Inspra approved in South Korea?
Yes. MFDS has authorised it; MFDS has authorised it; MFDS has authorised it.
Who is the marketing authorisation holder for Inspra in South Korea?
Upjohn is the originator. The local marketing authorisation holder may differ — check the official source linked above.